Literature DB >> 2567942

Treatment of biliary colic with loxiglumide.

C Beglinger, S Dill, B Meyer, B Werth, G Adler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567942     DOI: 10.1016/s0140-6736(89)90233-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Clinical pharmacology and therapeutics.

Authors:  M J Kendall; R C Horton
Journal:  Postgrad Med J       Date:  1990-03       Impact factor: 2.401

Review 2.  Perspectives of CCK antagonists in pancreatic research and clinical use. Part I.

Authors:  L C Rovati
Journal:  Int J Pancreatol       Date:  1991-04

3.  Effects of a new benzodiazepine derivative cholecystokinin receptor antagonist FK480 on pancreatic exocrine secretion in anesthetized rats.

Authors:  I Tachibana; M Otsuki
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

4.  Effect of three nonpeptide cholecystokinin antagonists on human isolated gallbladder.

Authors:  M A Maselli; A L Piepoli; F Pezzolla; V Guerra; M L Caruso; L Mennuni; D Lorusso; F Makovec
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

5.  Effects of somatostatin and loxiglumide on gallbladder motility.

Authors:  R J Lieverse; J B Jansen; M C Jebbink; A A Masclee; L C Rovati; C B Lamers
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 6.  Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.

Authors:  Marc J Berna; Robert T Jensen
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.